Monitoring of peanut-allergic patients with peanut-specific IgE

Size: px
Start display at page:

Download "Monitoring of peanut-allergic patients with peanut-specific IgE"

Transcription

1 Monitoring of peanut-allergic patients with peanut-specific IgE Rozita Borici-Mazi, M.D., Jorge A. Mazza, M.D., David W. Moote, M.D., and Keith B. Payton, M.D. ABSTRACT Peanut allergy affects 1% of the population. Double-blind placebo-controlled food challenges are gold standard for diagnosis. Serum peanut-specific IgE (PN-IgE) is used in clinical practice as an additional diagnostic and monitoring tool. The purpose of this study was to characterize the clinical features of a peanut-allergic patient s cohort and determine the optimum frequency of measuring PN-IgE to predict the outcome of future peanut challenges. Retrospective chart review was performed of peanut-allergic patients followed up and serially tested for PN-IgE with a qualitative antibody fluorescent-enzyme immunoassay performed at the Immunology Laboratory, London Health Sciences Center, from 1997 to One hundred eighteen patients (median age at first reaction to peanut, 1.5 years; median baseline PN-IgE, 18.75) were reviewed. Younger age at first reaction and first PN-IgE measurement predicted slower decline of PN-IgE values (p and p 0.044). At 2 and 5 years post initial measurement, 12.9 and 66%, respectively, of all patients had a significant decrease of PN-IgE values. Twenty percent of the patients experienced elevation of PN-IgE levels during follow-up. For most patients with significant history of reaction to peanuts and positive skin-prick test, it is probably adequate to measure serum PN-IgE levels every 3 5 years to screen for development of tolerance and predictproperty the outcome of future peanut challenges. More frequent measurements might be considered in older patients with lower initial PN-IgE levels. (Allergy Asthma Proc 29: , 2008; doi: /aap ) Key words: Long-term follow up, monitoring, natural history, oral challenge, peanut allergy, peanut-specific IgE, peanut tolerance practice, peanut-specific IgE (PN-IgE) is used to quantify the degree of sensitization and predict the development of tolerance to ingested peanut, thus reducing the number of double-blind placebo-controlled food challenge. 7 Recently, it has been shown that the peanut allergy is not necessarily a life-long condition. In a study of Skolnick et al., % of their peanut-allergic patients outgrew their allergy. Sixty-seven percent of their patients with PN-IgE levels 2 kilounits of antibody per liter (ku A /L) and 61% with levels 5 ku A /L had nega- Several longitudinal studies in the United States, tive challenge results. A second review of peanut-allergic England, and France have indicated that 1% of patients who underwent peanut challenges showed that the general population is allergic to peanuts. 1 3 A survey the level of PN-IgE of 5 ku A /L was associated with of primary school children, from kindergarten to 50% chance of outgrowing allergy. 9 The follow-up of grade 3, in Montreal, Canada, showed that the peanut peanut-allergic patients with PN-IgE, to identify those allergy prevalence was as high as 1.7%. 4 Recently, the patients who have the higher chance of passing future rate of peanut allergy among the children has increased. peanut challenges has been widely used. So far, only a 5,6 few studies have looked at the serial measurements of The gold standard for diagnosing peanut allergy is PN-IgE in peanut-allergic individuals. Vander Leek et the double-blind placebo-controlled foodoceanside challenge, Publications al. 10 compared two separate measurements of PN-IgE at which can be time-consuming and difficult. In clinical least 10 months apart in 18 peanut-allergic patients and found no significant difference. In 2004, van Odijk et al. published data on the change of PN-IgE over a 5-year interval in relation to peanut intake, symptoms, and age at first reaction. Thirty-four percent of their patients increased their PN-IgE, 28% had similar levels, whereas 38% decreased their PN-IgE. 11 The aim of this study was to characterize the clinical features of a peanut-allergic patient cohort and determine the optimum frequency of PN-IgE measurement to monitor for development of tolerance and predict the outcome of future peanut challenges. From the Division of Allergy and Clinical Immunology, Department of Medicine, University of Western Ontario, London, Canada Address correspondence and reprint requests to Rozita Borici-Mazi, M.D., University of Western Ontario, 60 Rollscourt Place, London, Ontario N6G 1M2, Canada address: rboricim@uwo.ca Copyright 2008, OceanSide Publications, Inc., U.S.A. METHODS Study Population Charts of peanut-allergic patients followed up at the Allergy Unit of London Health Sciences Center from 1997 to 2004 were reviewed. Patients were enrolled in Allergy and Asthma Proceedings 329

2 the study if they were 15 years old at the time of their first reaction to peanuts and had had at least two serial measurements of PN-IgE at least 1 year apart. Patients were diagnosed with peanut allergy if they had a history of an acute reaction to peanut within minutes after exposure and a positive skin-prick test (SPT) and/or PN-IgE. In 14 cases, patients were diagnosed as peanut sensitive based on positive SPT and radioallergosorbent test (RAST) to peanut without prior exposure. All peanut-sensitive patients and their families had implemented peanut avoidance measures. Open peanut challenges were offered during the follow-up if PN-IgE levels 2 ku A /L. The Ethics Committee of the University of Western Ontario approved this study and oral consent was obtained from the participants. Chart Review Patients charts were reviewed for symptoms of the initial reactions and number of accidental exposures to peanuts reported during follow-up visits. AdverseProperty re- this of definition, the patients were divided into two actions to peanuts were classified into (1) skin symptoms (including generalized hives/angioedema, contact urticaria, and worsening dermatitis), (2) respiratory symptoms, subdivided into mild (rhinitis and conjunctivitis) and severe (mouth swelling, throat tightness, laryngeal edema, cough, and wheezing), (3) gastrointestinal symptoms (nausea, vomiting, abdominal cramps, and diarrhea), and (4) anaphylactic shock (decreased blood pressure and impaired level of consciousness). Additional information recorded included gender, age at first reaction and first PN-IgE measurement, age at last PN-IgE measurement, and follow-up time. All available SPT results and PN-IgE values during follow-up were recorded. Associated Atopy and Other Food Allergies OceanSide Publications group 3, 100 ku A /L. Comparisons of survival curves Associated atopic conditions such as rhinitis, asthma, were made using log rank statistics. The frequencies of and atopic dermatitis were reviewed. The occurrence other atopic conditions and food allergies were calculated using the 2 -test. of other food allergies was documented and their diagnosis was based on a significant history of an acute reaction to one or more foods and positive SPT and/or specific IgE; selected open food challenges were performed as well. Laboratory Studies Skin tests were performed with standardized puncture method using Morrow-Brown style prick test needles (Allersharp; Quorum Pharmaceuticals, Mississauga, ON, Canada). A glycerinated extract of peanut along with positive (histamine) and negative (saline buffer solution) controls were used to perform SPTs. The wheal and flare reaction to peanut was measured at 15 minutes. The SPT to peanut was considered positive if the largest wheal diameter was 3 mm larger than the negative control. PN-IgE levels were measured with qualitative antibody fluorescent-enzyme immunoassay, Pharmacia CAP System RAST FEIA, performed at the Immunology Laboratory at London Health Sciences Center. The assay had a lower limit of detection of 0.35 ku A /L and an upper limit of 100 ku A /L. The positive results were rated based on CAP-RAST index as defined by manufacturer: , , , , , and 100 ku A /L. Values of 100 were arbitrarily assigned to 106 for statistical purposes. Statistical Analysis The primary end point was the time to a significant change of PN-IgE levels, which was calculated based on Kaplan-Meiers survival analysis. A significant change in PN-IgE levels was arbitrarily defined as the amount of decline/elevation of PN-IgE that allowed the second value to be rated in the lower/higher CAP- RAST class as defined by the manufacturer. Based on groups: (1) decline in PN-IgE and (2) increased PN-IgE. Other definitions used were (1) age at first reaction patient s age at first reaction to peanut, (2) age at first and last PN-IgE measurement patient s age at first and last PN-IgE measurement, and (3) follow-up time the time between first PN-IgE level and the level that showed significant change or the last PN-IgE level if such change did not occur. When the rate of decline on PN-IgE values was calculated for all of the patients, the serial measurements of PN-IgE were censored at the values that represented a significant increase of PN-IgE to minimize the confounding factors. For this analysis, patients were arbitrarily grouped based on initial PN-IgE value into group 1, 17.5 ku A /L; group 2, ku A /L; and RESULTS A total of 118 patients were reviewed, 75 male patients (63.55%) and 43 female patients. The age at first reaction ranged between 3 months and 15 years with a median value of 1.5 years (Table 1). Median baseline PN-IgE value was ku A /L with a range 0.36 to 100 ku A /L. As seen on the Table 1, 94 patients were diagnosed based on a significant history of an allergic reaction after exposure to peanuts, positive SPTs, and PN-IgE. Ten patients had a positive history and positive PN-IgE alone; of these, 6 patients did not undergo skin testing and 4 patients had a negative SPT to peanuts. Among patients with negative SPT to peanuts, two had PN-IgE of 100 ku A /L and their SPT converted to positive in retesting; the other two were not 330 May June 2008, Vol. 29, No. 3

3 Table 1 Patient characteristics Males n 75 (63.55%) Females n 43 (36.45%) Age at first reaction Age at first PN-IgE measurement Age at last PN-IgE measurement Baseline PN-IgE value Time to decrease in PN-IgE value (all patients) Follow up time No. diagnosed by History, SPT and PN-IgE n 94 History and PN-IgE n 10 SPT and/or PN-IgE/both n 12 PN-IgE n 2 Median (Range) 1.5 yr (3 mo 15 yr) 6.0 yr (1 25 yr) 8.0 yr (1 27 yr) ku A /L (0.36 to 100 ku A /L) 49 mos mos ( mos) retested and one of them had symptoms on accidental Table 2 Associated other atopic conditions and FAs exposure to peanuts. Fourteen patients were not exposed to peanuts. Of those, 12 had positive SPTs Property and of No. of PN-IgEs and two had positive PN-IgEs only. This Patients (%) group s mean PN-IgE value was ku A /L with a Associated Other Atopic Conditions range between 1.26 and 100 ku A /L. Asthma 51 (43) Seventy-three patients (61%) manifested other food Rhinitis 45 (38.1) allergies, the most common being tree nuts, eggs, and Atopic dermatitis 25 (21.2) milk (see Table 2). Tree nut allergy was present in Environmental allergies 73 (61.8) 35.6% of our peanut-allergic patient group. As shown Solitary food allergy 30 (25.4) in Table 2, asthma was the most common associated Solitary peanut allergy 4 (3.4) atopic condition; 30 patients suffered from food allergies only, whereas four manifested solitary peanut al- Other FAs Tree nuts 42 (57.3) lergy. Eggs 36 (49.3) One hundred four patients reacted significantly after Milk 27 (37) first known exposure to peanuts. Table 3 summarizes Vegetables 10 (13.7) the clinical characteristics of initial reactions to peanuts. Fifty-nine patients (56%) manifested skin symp- Fish/shellfish 7 (9.6) toms only, whereas six patients (5.76%) developed OceanSide anaphylactic shock after ingesting peanuts. The Publications Soya 7 (9.6) Grains 4 (5.5) Meats 3 (4.1) demographic features of the anaphylactic patients are presented in Table 4. The baseline PN-IgE level of patients that manifested skin symptoms only on exposure to peanuts (n 57; median PN-IgE, 18.7 ku A /L; SD 42.0) was not significantly different from the rest of the patients (n 44; median PN-IgE, 12.6 ku A /L; SD 42.1; p 0.387). All patients were followed up with serial testing of PN-IgE for months (median value) ranging between 13 and months. Ninety-four patients (79.6%) had a gradual decline of PN-IgE values, whereas 24 patients (20.4%) increased their PN-IgE during follow-up (Table 5). The patients who showed an elevation of PN-IgE were significantly younger at the time of their first reaction to peanuts compared with patients who showed a decline in PN-IgE (p 0.025) and their baseline PN-IgE values were significantly lower (p 0.01). Sesame 3 (4.1) Fruits 2 (2.7) Total individual FAs 141 FA food allergy. The patients who experienced a decline in PN-IgE levels were divided into three groups based on their baseline PN-IgE level. As shown in Table 6, the patients with a baseline PN-IgE level of kU A /L showed the highest rate (73%) of significant decline at 5 years, whereas those with initial PN-IgEs of 100 ku A /L had the least decline in PN-IgEs. In the latter group, only five patients (8%) decreased their initial PN-IgE level to the next RAST class ( ku A /L). At 2 and 5 years post initial PN-IgE measurement, 12.9 and 66.2% of all patients, Allergy and Asthma Proceedings 331

4 Table 3 Clinical characteristics of initial reaction to ingested peanuts Organ System Involved No. of patients Skin 59 Gastrointestinal 3 Respiratory 3 mild 3 severe Skin gastrointestinal 10 Skin respiratory 12 mild 6 severe Respiratory gastrointestinal 1 Skin respiratory gastrointestinal 1 Anaphylactic shock 6 Total 104 Skin: Contact rash or hives, generalized urticaria/angioedema, and worsening dermatitis. Gastrointestinal: Nausea, vomiting, abdominal cramps, and diarrhea. Respiratory: Mild symptoms, rhinitis and conjunctivitis; severe symptoms, throat tightness, mouth swelling, laryngeal edema, cough, and wheezing Anaphylactic shock: decreased blood pressure and decreased level of consciousness. Table 4 Demographic features and workup results Property of patients of who presented with anaphylactic shock after ingestion of peanuts Age (yr) Sex Accidental Exposure Skin Test Initial PN-IgE (ku A /L) Last PN-IgE (ku A /L) Associated Allergic Conditions 3 M Yes, A Rhinitis, asthma, and sesame allergy 15 F Yes, A Fish, shellfish, and tree nuts allergy 3 M No Asthma, environmental, fish, tree nuts, and carrot allergy 3 F Yes, A Not done Rhinitis, asthma, environmental, and egg allergy 1.5 F Yes, S RE Rhinitis and environmental allergy 3 M Yes, A Rhinitis, environmental, egg, and tree nuts allergy Table 5 Clinical characteristics of patients OceanSide grouped into Publications (a) patients with gradual decline of PN-IgE and (b) patients with PN-IgE elevation during follow-up PN-IgE Gradual PN-IgE Elevation p Decline Group Group Value Median/Mean Value Median/Mean Value Age first reaction (yr) 2.47/ / Age first RAST (yr) 7.15/ / Baseline RAST (ku A /L) 50.52/ / Last RAST (ku A /L) 44.47/ / Age at Last RAST (yr) 9.51/ / respectively, experienced a significant decline of their PN-IgE levels. The survival curves representing the PN-IgE level declines in each group of patients at 5 years post initial PN-IgE measurement are presented in Fig. 1. Additional analysis of the data from the serial PN-IgE measurements showed that the younger age at first reaction and PN-IgE measurement predicted a longer decline interval of PN-IgE levels (Fig. 2, A and B). Gender was not a predicting factor of PN-IgE decline interval (results not shown). Subgroup analysis of patients with atopic dermatitis showed that their decline in PN-IgE levels was not different from the rest of the patients (p 0.608). 332 May June 2008, Vol. 29, No. 3

5 Table 6 Patients Yearly decline rate of PN-IgE after initial measurement Total n 118 Baseline PN-IgE Level (ku A /L) <17.5 n n 30 >100 n 32 At 1 yr (95% CI) 4.7% ( %) 6.3% ( %) 3.5% ( %) 3.3% ( %) At 2 yr (95% CI) 12.9% ( %) 16.3% ( %) 12.3% ( %) 7.9% ( %) At 3 yr (95% CI) 28.9% ( %) 21.0% ( %) 48.8% ( %) 22.3% ( %) At 4 yr (95% CI) 47.5% ( %) 50.3% ( %) 59.1% ( %) 22.3% ( %) At 5 yr (95% CI) 66.2% ( %) 50.3% ( %) 72.7% ( %) NA Property of Figure 1. Decline rate (%) of PN-IgE as determined by baseline values (a) 17.5 ku A /L, (b) ku A /L, and (c) 100 ku A /L (106 values given for statistical purposes). Event-significant decline of PN-IgE value as defined. DISCUSSION This study was a retrospective chart review of a peanut-allergic patient cohort seen at our Allergy Clinic. These patients were diagnosed and followed up longitudinally based on significant history of reaction to peanuts, positive SPT, and serial measurements of PN-IgE. An important finding of this study was OceanSide that the Publications features of initial reaction to peanuts did not predict the magnitude of PN-IgE levels. Fifty-six percent IP: of our patients (59 of 104) manifested skin symptoms only at their first reaction to peanuts and their baseline PN-IgE levels did not differ significantly from those who manifested additional symptoms such as respiratory, gastrointestinal, or combination. Our findings are different from those reported by Vanderleek et al., 10 who showed a significant difference in peanut IgE levels between 11 patients who reacted with skin symptoms only and the other 51 patients who reacted with skin symptoms initially but had subsequent gastrointestinal and respiratory complaints on repeated exposures. Contrary to our study, they included not only symptoms during first reaction to peanuts, but also during subsequent exposures and peanut challenges. Second, as previously shown, PN-IgE levels vary greatly among patients, so the number of participants included in the analysis will affect the results as well. Figure 2. Decline rate (%) of PN-IgE as determined by (A) age at first reaction and (B) age at first PN-IgE measurement. Younger age at first reaction ( 2 years old) and first PN-IgE measurement ( 5 years old) predicted longer times for significant decline of PN-IgE (p and p 0.001, respectively). Twenty- three percent of our patients had atopic dermatitis, less commonly than previously reported. 8,9,12 Despite that, the baseline PN-IgE value (median, 18.5 ku A /L) of our cohort was high. This could have been caused by selection bias; therefore, patients Allergy and Asthma Proceedings 333

6 with higher baseline PN-IgE were more likely to get reaction to peanuts and the referral to the allergist repeated measurements and were selected for this review. and possibly because of reluctance of physicians and Despite higher baseline PN-IgE values, a sub- parents to perform blood tests in very young chil- group analysis of atopic dermatitis patients showed dren, which is a common occurrence in clinical practice. that atopic dermatitis had no effect on PN-IgE decline Our statistical analysis indicated that the pea- over time when compared with the patients without nut-allergic patients who were 5 years old at the atopic dermatitis. This finding could be of clinical significance time of first measurement of PN-IgE, had a lower when following up such patients. rate of significant decline in peanut-specific levels at During our longitudinal follow-up, we looked at 5 years when compared with older patients. Similarly, the repeated measurements of PN-IgE levels and van Odijk et al. have looked at PN-IgE levels at estimated the amount of change over time. To do baseline and 5 years later in 86 peanut-sensitive that, we used an arbitrary definition of PN-IgE significant patients and reported that patients who were 6 change, which does not necessarily translate years old at the time of initial tests were more likely into clinical significance but it was rather used here to have higher titers of PN-IgE when tested 5 years to measure the amount of decline. We found that a later than their older peers also tested after a 5-year great majority of our patients experienced a decline interval. 11 in PN-IgE levels during the follow-up. The rate of Another interesting finding of our study was that decline was a factor of the baseline value and the age 20% of our patients experienced an elevation of PNat first reaction to peanuts. Based on the initial peanut-specific IgE during follow-up despite the implementation of levels, our patients were grouped into peanut avoidance measures. These patients were sig- Property of three categories: 17.5, , and 100 ku A /L. nificantly younger (median age, 1.65 versus 2.47 At 5 years, the estimated highest rate of decline was years) at the time of the first reaction to peanuts and among the patients with baseline PN-IgE values between also had significantly lower baseline PN-IgE levels 17.5 and 100 ku A /L; 73% of patients in this (median value, ku A /L versus ku A /L) group would show a decline to the range of 3.5 when compared with those who showed a gradual ku A /L. On the contrary, only 8% of our patients decline in levels. There was no significant difference with baseline PN-IgE values of 100 ku A /L of the age at baseline PN-IgE measurement between would decline to the next CAP-RAST class two groups (p 0.349). These data suggest that ku A /L at 5-year follow-up. Based on our findings, younger patients (median, 1.65 years at first reaction) we can conclude that a patient with initial PN-IgE with lower baseline PN-IgE levels (median, level between 17.5 and 100 ku A /L has a three out of ku A /L) have not yet mounted the maximal four chance of having a decline of levels to the lower IgE-mediated response to peanuts at the time of the RAST class at the next measurement of PN-IgE 5 first evaluation; therefore, they are more likely to years apart, whereas a patient with initial PN-IgE experience elevation of levels in the next measurement. levels of 100 ku A /L is more likely to show no Another explanation could be that these chil- change in the subsequent measurement. Moreover, dren were exposed to traces of peanuts intermittently a dose that was adequate to elicit a PN-IgE one-half of patients with initial PN-IgEOceanSide values of Publications 17.5 ku A /L would have lower PN-IgE value in the elevation but not a clinical reaction. Similarly, Van next measurement, whereas the rest would be more likely to develop a plateau, where repeated measurements would show no significant change. The age at first reaction to peanuts was a significant predictor of PN-IgE decline. Patients who were 2 years old at the time of first reaction to peanuts were more likely to experience a longer decline interval of peanut-specific levels than their older peers (p 0.044). This might be explained by the fact that the same group of patients was more likely to show an elevation of PN-IgE titers initially and then experience decline. The decline of PN-IgE levels was similarly predicted by the patient s age at first PN-IgE measurement. The median age at first reaction to peanuts was 1.5 years, whereas at first PN-IgE measurement age was 6 years, 4.5 years later. We think that this delay has to do with the time gap between the first Odijk et al. documented an elevation of peanut-specific levels during their follow-up and concluded that exposure to peanuts during the study, i.e., 5 6 years since diagnosis did not seem to affect the PN- IgE levels. 11 More studies are required to elucidate the causes of PN-IgE elevation despite the implementation of peanut avoidance measures. Several studies have looked at the relationship between the PN-IgE levels and results of upcoming peanut challenges in peanut-allergic patients. 7 9,13 PN-IgE levels 15 ku A /L have been reported to have a 95% likelihood of predicting a positive peanut challenge. 12 Perry et al. recommended that for patients with a clear history of reaction to peanuts a challenge should be considered when the PN-IgE level is 2 ku A /L and the chance of passing it is approximately 50%. 7 Our cohort had a median baseline PN-IgE value 18.5 ku A /L. Among 104 patients with a clear history of 334 May June 2008, Vol. 29, No. 3

7 reaction to peanuts, only 14 patients (13.5%) had a decline of PN-IgE to 2 ku A /L during 5-year follow-up and open peanut challenges were offered. The survival curves of PN-IgE levels over a 5-year period showed an overall 12.9 and 66.2% decline rate at 2 and 5 years post initial measurement and there were significant differences among patient groups based on initial PN-IgE values, age at first reaction to peanuts, and first measurement of PN-IgE levels, as previously mentioned. With the data from this study, we can recommend that for most of the patients with significant history of reaction to peanuts and positive SPT, it probably is adequate to check PN-IgE at baseline and every 3 5 years to monitor the PN-IgE decline to levels with higher prediction of negative future peanut challenges. More frequent measurements might be considered in older kids with lower baseline PN-IgE levels. This study was a retrospective review and as such has several limitations. The decision to order PN-RAST Property of REFERENCES testing of the patients was arbitrary. Some patients had lack of regular yearly follow-up, so the intervals between PN-RAST testing were not uniform. At last, while all patients avoided peanuts, the other atopic conditions/food allergies were not controlled uniformly as they would be in a prospective study. Despite the limitations, this is the first study that reviews data from monitoring peanut- allergic patients with PN-IgE to identify in a timely fashion those patients with the greatest likelihood of a future negative challenge. It would be interesting to see if our data can be replicated in other peanut-allergic patient cohorts. Our recommendation would be of assistance for allergists, pediatricians, and family physicians wishing to minimize the frequency of blood taking, which can be especially unpleasant for younger children. OceanSide Publications 1. Sicherer SH, Munoz-Furlong BA, Burks AW, and Sampson HA. Prevalence of peanut and tree allergy in US determined by a random digital telephone survey. J Allergy Clin Immunol 103: , Kanny G, Moneret-Vautrin DA, Flabbee J, et al. Population study of food allergy in France. J Allergy Clin Immunol 108: , Emmet SE, Angus FJ, Fry JS, and Lee PN. Perceived prevalence of peanut allergy in Great Britain and its association with other atopic conditions and with other household members. Allergy 54: , Sicherer SH, Munoz-Furlong A, and Sampson HA. Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: A 5-year follow-up study. J Allergy Clin Immunol 112: , Grundy J, Matthews S, Bateman B, et al. Rising prevalence of allergy to peanut in children: Data from 2 sequential cohorts. J Allergy Clin Immunol 110: , Kagan RS, Joseph L, Dufresne C, et al. Prevalence of peanut allergy in primary-school children in Montreal, Canada. J Allergy Clin Immunol 112: , Perry T, Matsui Elisabeth, Conover-Walker MK, and Wood RA. The relationship of allergen-specific IgE and oral food challenge outcome. J Allergy Clin Immunol 114: , Skolnick HS, Conover-Walker MK, Koerner CB, et al. The natural history of peanut allergy. J Allergy Clin Immunol 107: , Fleischer DM, Conover-Walker MK, Christie L, et al. The natural progression of peanut allergy: Resolution and the possibility of recurrence. J Allergy Clin Immunol 112: , Vander Leek TK, Liu AH, Stefanski K, et al. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Pediatr 137: , van Odijk J, Bengtsson U, Borres MP, et al. Specific immunoglobulin E antibodies to peanut over time in relation to peanut intake, symptoms and age. Pediatr Allergy Immunol 15: , Sampson HA, and Ho DG. Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol 100: , Carr WW. Clinical pearls and pitfalls: Peanut allergy. Allergy Asthma Proc 26: , e Allergy and Asthma Proceedings 335

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Burks AW, Jones SM, Wood RA, et al. Oral immunotherapy for

More information

Diagnosing peanut allergy with skin prick and specific IgE testing

Diagnosing peanut allergy with skin prick and specific IgE testing Diagnosing peanut allergy with skin prick and specific IgE testing Graham Roberts, DM, Gideon Lack, FRCPCH, and the Avon Longitudinal Study of Parents and Children Study Team London, United Kingdom Background:

More information

Threshold levels in food challenge and specific IgE in patients with egg allergy: Is there a relationship?

Threshold levels in food challenge and specific IgE in patients with egg allergy: Is there a relationship? Threshold levels in food challenge and specific IgE in patients with egg allergy: Is there a relationship? Morten Osterballe, MD, and Carsten Bindslev-Jensen, MD, PhD, DSc Odense, Denmark Background: Previously

More information

Rand E. Dankner, M.D. Jacqueline L. Reiss, M. D.

Rand E. Dankner, M.D. Jacqueline L. Reiss, M. D. Tips to Remember: Food allergy Up to 2 million, or 8%, of children, and 2% of adults in the United States are estimated to have food allergies. With a true food allergy, an individual's immune system will

More information

Food Allergy Update: To Feed or Not to Feed?

Food Allergy Update: To Feed or Not to Feed? Food Allergy Update: To Feed or Not to Feed? Myngoc Nguyen, M.D. Allergy Department KP EBA Objectives: Prevalence of food allergy, clinical manifestation, diagnosis,component testing, oral challenges.

More information

Author s response to reviews

Author s response to reviews Author s response to reviews Title: The epidemiologic characteristics of healthcare provider-diagnosed eczema, asthma, allergic rhinitis, and food allergy in children: a retrospective cohort study Authors:

More information

Peanut Allergy Desensitization

Peanut Allergy Desensitization Peanut Allergy Desensitization DERRICK R. WARD, MD KANSAS CITY ALLERGY AND ASTHMA ASSOCIATES KAAP SPRING CME MEETING APRIL 24, 2015 Disclosures Speakers Bureau Teva pharmaceuticals Consultant None Research

More information

Food allergens: Challenges for risk assessment

Food allergens: Challenges for risk assessment Food allergens: Challenges for risk assessment Stefano Luccioli, MD Office of Food Additive Safety Center for Food Safety and Applied Nutrition Goals Introduce food allergy Describe challenges for risk

More information

Path2220 INTRODUCTION TO HUMAN DISEASE ALLERGY. Dr. Erika Bosio

Path2220 INTRODUCTION TO HUMAN DISEASE ALLERGY. Dr. Erika Bosio Path2220 INTRODUCTION TO HUMAN DISEASE ALLERGY Dr. Erika Bosio Research Fellow Centre for Clinical Research in Emergency Medicine, Harry Perkins Institute of Medical Research University of Western Australia

More information

EPIPEN INSERVICE Emergency Administration of Epinephrine for the Basic EMT. Michael J. Calice MD, FACEP St. Mary Mercy Hospital

EPIPEN INSERVICE Emergency Administration of Epinephrine for the Basic EMT. Michael J. Calice MD, FACEP St. Mary Mercy Hospital EPIPEN INSERVICE Emergency Administration of Epinephrine for the Basic EMT Michael J. Calice MD, FACEP St. Mary Mercy Hospital Case #1 NR is an 8 yo male c/o hot mouth and stomach ache after eating jelly

More information

YVONNE POLYDOROU PAEDIATRIC ALLERGY SPECIALIST DIETITIAN

YVONNE POLYDOROU PAEDIATRIC ALLERGY SPECIALIST DIETITIAN YVONNE POLYDOROU PAEDIATRIC ALLERGY SPECIALIST DIETITIAN 08-12-2016 An allergy is the response of the body's immune system to normally harmless substances, such as pollens, foods, and house dust mite.

More information

2/10/2017 THE NUTS AND BOLTS OF FOOD ALLERGY LEARNING OBJECTIVES DEFINITIONS

2/10/2017 THE NUTS AND BOLTS OF FOOD ALLERGY LEARNING OBJECTIVES DEFINITIONS THE NUTS AND BOLTS OF FOOD ALLERGY Amanda Hess, MMS, PA-C San Tan Allergy & Asthma Arizona Allergy & Immunology Research Gilbert, Arizona LEARNING OBJECTIVES 1. Discuss the epidemiology, natural history

More information

Food allergy in children. nice bulletin. NICE Bulletin Food Allergy in Chlidren.indd 1

Food allergy in children. nice bulletin. NICE Bulletin Food Allergy in Chlidren.indd 1 nice bulletin Food allergy in children NICE provided the content for this booklet which is independent of any company or product advertised NICE Bulletin Food Allergy in Chlidren.indd 1 23/01/2012 11:04

More information

Food Allergy. Wesley Burks, M.D. Curnen Distinguished Professor and Chair Department of Pediatrics University of North Carolina

Food Allergy. Wesley Burks, M.D. Curnen Distinguished Professor and Chair Department of Pediatrics University of North Carolina Food Allergy Wesley Burks, M.D. Curnen Distinguished Professor and Chair Department of Pediatrics University of North Carolina Faculty disclosure FINANCIAL INTERESTS I have disclosed below information

More information

New Developments in Food Allergies, Prevention & Treatment

New Developments in Food Allergies, Prevention & Treatment New Developments in Food Allergies, Prevention & Treatment Michael Daines, M.D. Associate Professor, Pediatric Allergy and Immunology Division director, Pediatric Allergy, Immunology, and Rheumatology

More information

Natural history of insect ir, g allergy: Relationship of severity of sym oms of initial sting anaphylaxis to re-sting rea ions

Natural history of insect ir, g allergy: Relationship of severity of sym oms of initial sting anaphylaxis to re-sting rea ions Natural history of insect ir, g allergy: Relationship of severity of sym oms of initial sting anaphylaxis to re-sting rea ions Robert E. Reisman, MD Buffalo, N.Y. To examine the postulate that the nature

More information

Appendix 9B. Diagnosis and Management of Infants with Suspected Cow s Milk Protein Allergy.

Appendix 9B. Diagnosis and Management of Infants with Suspected Cow s Milk Protein Allergy. Appendix 9B Diagnosis and Management of Infants with Suspected Cow s Milk Protein Allergy. A guide for healthcare professionals working in primary care. This document aims to provide health professionals

More information

Food Allergies. (Demkin). That is approximately two million kids. That number only represents children, but

Food Allergies. (Demkin). That is approximately two million kids. That number only represents children, but McCurry!1 Bailey McCurry Kennon Biology I Honors 1 May 2018 Food Allergies Food allergies are becoming more common in today s society. More people have allergies than you might think. Research says that

More information

Allergy Management Policy

Allergy Management Policy Allergy Management Policy Food Allergy People with allergies have over-reactive immune systems that target otherwise harmless elements of our diet and environment. During an allergic reaction to food,

More information

Improved screening for peanut allergy by the combined use of skin prick tests and specific IgE assays

Improved screening for peanut allergy by the combined use of skin prick tests and specific IgE assays Improved screening for peanut allergy by the combined use of skin prick tests and specific IgE assays Fabienne Rancé, MD, Michel Abbal, MD, and Valérie Lauwers-Cancès, MD Toulouse, France Background: The

More information

Food Allergy Advances in Diagnosis

Food Allergy Advances in Diagnosis 22 nd World Allergy Congress Food Allergy Advances in Diagnosis By: Hugh A. Sampson, M.D. Food Allergy Advances in Diagnosis Hugh A. Sampson, M.D. Professor of Pediatrics & Immunology Dean for Translational

More information

Anaphylaxis in the Community

Anaphylaxis in the Community Anaphylaxis in the Community ACES101210 Copyright 2010, AANMA www.aanma.org ACES2015 ACES101210 Copyright Copyright 2015 2010, Allergy AANMA & Asthma www.aanma.org Network AllergyAsthmaN Anaphylaxis Community

More information

By the end of this lecture physicians will:

By the end of this lecture physicians will: No disclosure By the end of this lecture physicians will: 1. Be able to identify patients who need immune work-up. 2. Be able to recognize the manifestation of food allergies. 3. Be knowledgeable about

More information

Omalizumab (Xolair ) ( Genentech, Inc., Novartis Pharmaceuticals Corp.) September Indication

Omalizumab (Xolair ) ( Genentech, Inc., Novartis Pharmaceuticals Corp.) September Indication ( Genentech, Inc., Novartis Pharmaceuticals Corp.) September 2003 Indication The FDA recently approved Omalizumab on June 20, 2003 for adults and adolescents (12 years of age and above) with moderate to

More information

Food Allergy , The Patient Education Institute, Inc. imf10101 Last reviewed: 10/15/2017 1

Food Allergy , The Patient Education Institute, Inc.  imf10101 Last reviewed: 10/15/2017 1 Food Allergy Introduction A food allergy is an abnormal response to a food. It is triggered by your body's immune system. An allergic reaction to a food can sometimes cause severe illness or death. Tree

More information

Management of the Patient with Multiple Food Allergies

Management of the Patient with Multiple Food Allergies Curr Allergy Asthma Rep (2010) 10:271 277 DOI 10.1007/s11882-010-0116-0 Management of the Patient with Multiple Food Allergies Julie Wang Published online: 30 April 2010 # Springer Science+Business Media,

More information

FOOD ALLERGY AND WHEEZING

FOOD ALLERGY AND WHEEZING FOOD ALLERGY AND WHEEZING Jarungchit Ngamphaiboon Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand The pattern of allergy in developed countries has been changing

More information

Food Allergy I. William Reisacher, MD FACS FAAOA Department of Otorhinolaryngology Weill Cornell Medical College

Food Allergy I. William Reisacher, MD FACS FAAOA Department of Otorhinolaryngology Weill Cornell Medical College Food Allergy I William Reisacher, MD FACS FAAOA Department of Otorhinolaryngology Weill Cornell Medical College History of Food Allergy Old Testament - Hebrews place dietary restrictions in order to prevent

More information

Policy for the Treatment of Anaphylaxis in Adults and Children

Policy for the Treatment of Anaphylaxis in Adults and Children Policy for the Treatment of Anaphylaxis in Adults and Children June 2008 Policy Title: Policy for the Treatment of Anaphylaxis in Adults or Children Policy Reference Number: PrimCare08/17 Implementation

More information

Clinical features and respiratory comorbidity in Hong Kong children with peanut allergy

Clinical features and respiratory comorbidity in Hong Kong children with peanut allergy Original Article Journal of Paediatric Respirology and Critical Care Clinical features and respiratory comorbidity in Hong Kong children with peanut allergy Ting-Fan LEUNG Department of Paediatrics, The

More information

St. Joseph s Primary School Numurkah

St. Joseph s Primary School Numurkah St. Joseph s Primary School Numurkah Anaphylaxis Procedure March 2014 Basic Beliefs: Our school community nurtures the development of the whole child. Our School is built on respect and an appreciation

More information

Management of ANAPHYLAXIS in the School Setting. Updated September 2010

Management of ANAPHYLAXIS in the School Setting. Updated September 2010 Management of ANAPHYLAXIS in the School Setting Updated September 2010 What is an Allergy? Allergies occur when the immune system becomes unusually sensitive and over reacts to common substance that are

More information

Allergy Testing in Childhood: Using Allergen-Specific IgE Tests

Allergy Testing in Childhood: Using Allergen-Specific IgE Tests Guidance for the Clinician in Rendering Pediatric Care CLINICAL REPORT Allergy Testing in Childhood: Using Allergen-Specific IgE Tests Scott H. Sicherer, MD, Robert A. Wood, MD, and the SECTION ON ALLERGY

More information

Food Allergens. Food Allergy. A Patient s Guide

Food Allergens. Food Allergy. A Patient s Guide Food Allergens Food Allergy A Patient s Guide Food allergy is an abnormal response to a food triggered by your body s immune system. About 3 percent of children and 1 percent of adults have food allergy.

More information

Food-allergy-FINAL.mp3. Duration: 0:07:39 START AUDIO

Food-allergy-FINAL.mp3. Duration: 0:07:39 START AUDIO BMJ LEARNING VIDEO TRANSCRIPT File: Duration: 0:07:39 Food-allergy-FINAL.mp3 START AUDIO Adam Fox: Food allergy is an inappropriate immune response to food. Our immune systems should ignore food completely,

More information

Discover the connection

Discover the connection Mike is about to have gastrointestinal symptoms, and his parents won t know why Milk Soy milk Wheat bread Egg FOOD ALLERGY Symptoms and food allergies Discover the connection ImmunoCAP Complete Allergens

More information

Putting It Together: NIAID- Sponsored 2010 Guidelines for Managing Food Allergy

Putting It Together: NIAID- Sponsored 2010 Guidelines for Managing Food Allergy American Academy of Allergy, Asthma and Immunology FIT Symposium # 1011 Putting It Together: NIAID- Sponsored 2010 Guidelines for Managing Food Allergy February 22, 2013 11:45 AM Scott H. Sicherer, MD

More information

Food Diversity in the First Year of Life and the Development of Allergic Disease in High-Risk Children. By Cheryl Hirst. Supervisor: Dr.

Food Diversity in the First Year of Life and the Development of Allergic Disease in High-Risk Children. By Cheryl Hirst. Supervisor: Dr. Food Diversity in the First Year of Life and the Development of Allergic Disease in High-Risk Children By Cheryl Hirst Supervisor: Dr. Meghan Azad A Capstone Project Submitted to the Faculty of Graduate

More information

Prevalence of self-reported food allergy in Cartagena (Colombia) population

Prevalence of self-reported food allergy in Cartagena (Colombia) population Prevalence of self-reported food allergy in Cartagena (Colombia) population J. Marrugo, L. Hernández and V. Villalba Instituto de Investigaciones Inmunológicas. Universidad de Cartagena. Colombia. ABSTRACT

More information

Accidental allergic reactions in children allergic to cow s milk proteins

Accidental allergic reactions in children allergic to cow s milk proteins Food, drug, insect sting allergy, and anaphylaxis Accidental allergic reactions in children allergic to cow s milk proteins Teresa Boyano-Martínez, MD, a Carmen García-Ara, MD, PhD, a María Pedrosa, MD,

More information

Conference Call for Investment Community. Nov 19, 2018

Conference Call for Investment Community. Nov 19, 2018 Conference Call for Investment Community Nov 19, 2018 Agenda for Today s Call Topic Safe Harbor Statement Opening Remarks AR101 for Peanut Allergy Speaker Laura Hansen, PhD, VP, Investor Relations Jayson

More information

1

1 1 2 3 4 5 6 Scratch and Sniff All About Allergies Doug Jones, MD Program Director, Family Medicine, DHMG What is an allergic reaction? The immune system identifies things that are foreign and protects

More information

ADVANCED DIPLOMA IN PRINCIPLES OF NUTRITION

ADVANCED DIPLOMA IN PRINCIPLES OF NUTRITION ADVANCED DIPLOMA IN PRINCIPLES OF NUTRITION BY LAUREN OWENS RD BSC (HONS) Human Nutrition and DIetetics Course Educators: Thomas Woods, William Eames BY LAUREN OWENS @ShawPhotoTom Special Diets Semester

More information

FDA/NSTA Web Seminar: Teach Science Concepts and Inquiry with Food

FDA/NSTA Web Seminar: Teach Science Concepts and Inquiry with Food LIVE INTERACTIVE LEARNING @ YOUR DESKTOP FDA/NSTA Web Seminar: Teach Science Concepts and Inquiry with Food Thursday, November 15, 2007 Food allergy Stefano Luccioli, MD Office of Food Additive Safety

More information

REFERRAL GUIDELINES - SUMMARY

REFERRAL GUIDELINES - SUMMARY Clinical Immunology & Allergy Unit LEEDS TEACHING HOSPITALS NHS TRUST REFERRAL GUIDELINES - SUMMARY THESE GUIDELINES ARE DESIGNED TO ENSURE THAT PATIENTS REQUIRING SECONDARY CARE ARE SEEN EFFICIENTLY AND

More information

20/11/55. Food Allergy and Atopic Dermatitis. Outline of Talk - 1. Outline of talk - 2

20/11/55. Food Allergy and Atopic Dermatitis. Outline of Talk - 1. Outline of talk - 2 Food Allergy and Atopic Dermatitis Pakit Vichyanond, MD Department of Pediatrics Faculty of Medicine Siriraj Hospital Mahidol University, Bangkok, Thailand Outline of Talk - 1 Frequency of food sensitization

More information

Allergy and Immunology Review Corner: Chapter 71 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al.

Allergy and Immunology Review Corner: Chapter 71 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al. Allergy and Immunology Review Corner: Chapter 71 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al. Chapter 71: In Vivo Study of Allergy Prepared by Jacob

More information

Food Allergy Testing and Guidelines

Food Allergy Testing and Guidelines Food Allergy Testing and Guidelines Dr Gosia Skibinska Primary Care Allergy Training Day, 15 th October 2011 Food Allergy Testing and Guidelines Food allergy Testing Guidelines Cases Food Allergy NICE

More information

Recognition & Management of Anaphylaxis in the Community. S. Shahzad Mustafa, MD, FAAAAI

Recognition & Management of Anaphylaxis in the Community. S. Shahzad Mustafa, MD, FAAAAI Recognition & Management of Anaphylaxis in the Community S. Shahzad Mustafa, MD, FAAAAI Disclosures None Outline Define anaphylaxis Pathophysiology Common causes Recognition and Management Definition Acute,

More information

7/25/2016. Use of Epinephrine in the Community. Knowledge Amongst Paramedics. Knowledge Amongst Paramedics survey of 3479 paramedics

7/25/2016. Use of Epinephrine in the Community. Knowledge Amongst Paramedics. Knowledge Amongst Paramedics survey of 3479 paramedics Recognition & Management of Anaphylaxis in the Community S. Shahzad Mustafa, MD, FAAAAI Disclosures Speaker s bureau Genentech, Teva Consultant Genentech, Teva Outline Knowledge gap Definition Pathophysiology

More information

Skin prick testing: Guidelines for GPs

Skin prick testing: Guidelines for GPs INDEX Summary Offered testing but where Allergens precautions are taken Skin prick testing Other concerns Caution Skin testing is not useful in these following conditions When skin testing is uninterpretable

More information

A Progression of Seemingly Unrelated Symptoms. Identifying and Managing Potential Allergic Food and Respiratory Sensitivities

A Progression of Seemingly Unrelated Symptoms. Identifying and Managing Potential Allergic Food and Respiratory Sensitivities A Progression of Seemingly Unrelated Symptoms Identifying and Managing Potential Allergic Food and Respiratory Sensitivities Talk to your doctor if you or your loved one have experienced or is currently

More information

Persistent food allergy might present a more challenging situation. Patients with the persistent form of food allergy are likely to have a less

Persistent food allergy might present a more challenging situation. Patients with the persistent form of food allergy are likely to have a less Iride Dello Iacono Food allergy is an increasingly prevalent problem in westernized countries, and there is an unmet medical need for an effective form of therapy. A number of therapeutic strategies are

More information

Myth: Prior Episodes Predict Future Reactions REALITY: No predictable pattern Severity depends on: Sensitivity of the individual Dose of the allergen

Myth: Prior Episodes Predict Future Reactions REALITY: No predictable pattern Severity depends on: Sensitivity of the individual Dose of the allergen Myth: Prior Episodes Predict Future Reactions REALITY: No predictable pattern Severity depends on: Sensitivity of the individual Dose of the allergen Anaphylaxis Fatalities Estimated 500 1000 deaths annually

More information

VACCINE-RELATED ALLERGIC REACTIONS

VACCINE-RELATED ALLERGIC REACTIONS VACCINE-RELATED ALLERGIC REACTIONS Management of Anaphylaxis Public Health Immunization Program June 2018 VACCINE-RELATED ADVERSE EVENTS Local reactions pain, edema, erythema Systemic reactions fever,

More information

Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm

Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm Allergic Disorders Anne-Marie Irani, MD Virginia Commonwealth University Allergic Disorders IgE-mediated immune reactions Clinical entities include: asthma allergic rhinitis atopic dermatitis urticaria

More information

Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm

Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm Allergic Disorders Anne-Marie Irani, MD Virginia Commonwealth University Allergic Disorders IgE-mediated immune reactions Clinical entities include: asthma allergic rhinitis atopic dermatitis urticaria

More information

Pediatric Allergy Allergy Related Testing

Pediatric Allergy Allergy Related Testing Pediatric Allergy Allergy Related Testing 1 Allergies are reactions that are usually caused by an overactive immune system. These reactions can occur in a variety of organs in the body, resulting in conditions

More information

An allergic reaction is an exaggerated response by the immune system to a foreign substance

An allergic reaction is an exaggerated response by the immune system to a foreign substance ALLERGIC REACTION An allergic reaction is an exaggerated response by the immune system to a foreign substance Anaphylaxis is an unusual or exaggerated allergic reaction; is a life threatening emergency

More information

Food and drug reactions and anaphylaxis

Food and drug reactions and anaphylaxis The distribution of individual threshold doses eliciting allergic reactions in a population with peanut allergy Marjolein Wensing, MD, a André H. Penninks, PhD, b Susan L. Hefle, PhD, c Stef J. Koppelman,

More information

Sesame seed sensitization in a group of atopic Egyptian children

Sesame seed sensitization in a group of atopic Egyptian children Egypt J Pediatr Allergy Immunol 2013;11(2):63-67. Original article Sesame seed sensitization in a group of atopic Egyptian children Background: There are no published data on the prevalence of sesame allergy/sensitization

More information

A new protocol for specific oral tolerance induction in children with IgE-mediated cow s milk allergy DO NOT COPY

A new protocol for specific oral tolerance induction in children with IgE-mediated cow s milk allergy DO NOT COPY A new protocol for specific oral tolerance induction in children with IgE-mediated cow s milk allergy Lucia Caminiti, M.D., 1 Giovanni Passalacqua, M.D., 2 Salvatore Barberi, M.D., 3 Daniela Vita, M.D.,

More information

Hypersensitivity Reactions and Peanut Component Testing 4/17/ Mayo Foundation for Medical Education and Research. All rights reserved.

Hypersensitivity Reactions and Peanut Component Testing 4/17/ Mayo Foundation for Medical Education and Research. All rights reserved. 1 Hello everyone. My name is Melissa Snyder, and I am the director of the Antibody Immunology Lab at the Mayo Clinic in Rochester, MN. I m so glad you are able to join me for a brief discussion about the

More information

Objectives. Protein and Allergy. IgE mediated Food Allergy 11/1/2016. Manifestations of Food Allergy to Cow Milk Proteins

Objectives. Protein and Allergy. IgE mediated Food Allergy 11/1/2016. Manifestations of Food Allergy to Cow Milk Proteins Objectives tein and Allergy Kent Woo, MD (USA) Allergy/Immunology Internal Medicine Describe manifestations of cow milk protein allergy Go over the relevant cow milk protein allergens Discuss on what hydrolyzed

More information

New Test ANNOUNCEMENT

New Test ANNOUNCEMENT March 2003 W New Test ANNOUNCEMENT A Mayo Reference Services Publication Pediatric Allergy Screen

More information

LIFE THREATENING ALLERGIES POLICY

LIFE THREATENING ALLERGIES POLICY LIFE THREATENING ALLERGIES POLICY What is Anaphylaxis? Anaphylaxis is a severe systemic allergic reaction at the extreme end of the allergic spectrum. The whole body is affected usually within minutes

More information

Eczema: also called atopic dermatitis; a chronic, itchy, scaly rash not due to a particular substance exposure

Eczema: also called atopic dermatitis; a chronic, itchy, scaly rash not due to a particular substance exposure Allergy is a condition in which the immune system causes sneezing, itching, rashes, and wheezing, or sometimes even life-threatening allergic reactions. The more you know about allergies, the better prepared

More information

ELWOOD COLLEGE PROGRAM: ANAPHYLAXIS MANAGEMENT POLICY NO: 4 DATE: 09/02/10

ELWOOD COLLEGE PROGRAM: ANAPHYLAXIS MANAGEMENT POLICY NO: 4 DATE: 09/02/10 ELWOOD COLLEGE Glenhuntly Rd, Elwood, 3184, Telephone 9531 9566 PROGRAM: ANAPHYLAXIS MANAGEMENT POLICY NO: 4 DATE: 09/02/10 PURPOSE: 1. To provide, as far as practicable, a safe school environment in which

More information

Mosquito Allergy in Children: Clinical features and limitation of commercially-available diagnostic tests

Mosquito Allergy in Children: Clinical features and limitation of commercially-available diagnostic tests Asian Pacific Journal of Allergy and Immunology ORIGINAL ARTICLE Mosquito Allergy in Children: Clinical features and limitation of commercially-available diagnostic tests Wiparat Manuyakorn, Sulak Itsaradisaikul,

More information

What is allergy? Know your specific IgE

What is allergy? Know your specific IgE What is allergy? What is allergy? Know your specific IgE Allergies are very common and increasing in Australia and New Zealand, affecting around one in three people at some time in their lives. There are

More information

Feed those babies some peanut products!!!

Feed those babies some peanut products!!! Disclosures Feed those babies some peanut products!!! No relevant disclosures Edward Brooks Case presentation 5 month old male with severe eczema starting at 3 months of age. He was breast fed exclusively

More information

Food Allergy Clinical Trials

Food Allergy Clinical Trials Food Allergy Clinical Trials Jacqueline Pongracic, MD Division Head, Allergy/Immunology Professor of Pediatrics and Medicine Northwestern University Feinberg School of Medicine Outline Introduction Approaches

More information

The importance of early complementary feeding in the development of oral tolerance: Concerns and controversies

The importance of early complementary feeding in the development of oral tolerance: Concerns and controversies The importance of early complementary feeding in the development of oral tolerance: Concerns and controversies Prescott SL, Smith P, Tang M, Palmer DJ, Sinn J, Huntley SJ, Cormack B. Heine RG. Gibson RA,

More information

Allergy Awareness & EpiPen Administration

Allergy Awareness & EpiPen Administration Allergy Awareness & EpiPen Administration 2017-18 Common Allergens in Children! Shellfish! Milk! Egg! Peanut! Tree Nuts! Fish! Soy! Latex! Insect Stings! Exercise What is an allergy? * An allergy is an

More information

GET TRAINED. What Would You Do? You have moments to react. Bianca 1/15/2014 GET TRAINED

GET TRAINED. What Would You Do? You have moments to react. Bianca 1/15/2014 GET TRAINED GET TRAINED It s time to GET TRAINED to administer an epinephrine auto-injector in an emergency! What Would You Do? Bianca has a bee sting allergy She is playing in the garden at her friends house She

More information

MMO CLINIC MAYO CLINIC

MMO CLINIC MAYO CLINIC MMO CLINIC Overview Allergies occur when your immune system reacts to a foreign substance such as pollen, bee venom or pet dander or to a food that doesn't cause a reaction in most people. Your immune

More information

Asthma With a Slight Chance of Anaphylaxis

Asthma With a Slight Chance of Anaphylaxis Asthma With a Slight Chance of Anaphylaxis An Update for Alberta Oral Health Professionals Sept 25/13 Presented by Val Olson CRE Community Pediatric Asthma Service Air passes through the: Nose or mouth

More information

University of Texas Health Science Center at San Antonio. Pediatrics Grand Rounds 11 December 2009 FACULTY DISCLOSURE

University of Texas Health Science Center at San Antonio. Pediatrics Grand Rounds 11 December 2009 FACULTY DISCLOSURE Food Allergy: Why is Everyone Going Nuts? Wesley Burks, M.D. Professor and Chief Pediatric Allergy and Immunology Duke University Medical Center FACULTY DISCLOSURE FINANCIAL INTERESTS I have disclosed

More information

3/19/18. Food Allergy. Hot Topics in Food Allergies: A Panel Discussion

3/19/18. Food Allergy. Hot Topics in Food Allergies: A Panel Discussion Hot Topics in Food Allergies: A Panel Discussion JEFFREY M FACTOR MD, ALLERGIST RACHEL POWELL, RN TRICIA DONOVAN, PARENT MARCH 22, 2018 https://www.google.com/imgres?imgu rl=http://www.therootofhealth.com/sto

More information

Student Health Center

Student Health Center Referring Allergist Agreement Your patient is requesting that the University of Mary Washington Student Health Center (UMWSHC) administer allergy extracts provided by your office. Consistent with our policies

More information

Local Coverage Determination (LCD): RAST Type Tests ( L30524 )

Local Coverage Determination (LCD): RAST Type Tests ( L30524 ) Page 2 of 6 Local Coverage Determination (LCD): RAST Type Tests ( L30524 ) Contractor Information Contractor Name Novitas Solutions, Inc. Contract Number 12502 Contract Type A and B MAC LCD Information

More information

EAACI Presentation by Wesley Burks, MD June 7, 2015 Barcelona, Spain

EAACI Presentation by Wesley Burks, MD June 7, 2015 Barcelona, Spain A Novel Characterized Peanut Allergen Formulation (AR101) for Oral Immunotherapy (OIT) Induces Desensitization in Peanut-Allergic Subjects: A Phase 2 Clinical Safety and Efficacy Study Bird JA, Spergel

More information

Urticaria Moderate Allergic Reaction Mild signs/symptoms with any of following: Dyspnea, possibly with wheezes Angioneurotic edema Systemic, not local

Urticaria Moderate Allergic Reaction Mild signs/symptoms with any of following: Dyspnea, possibly with wheezes Angioneurotic edema Systemic, not local Allergic Reactions & Anaphylaxis Incidence In USA - 400 to 800 deaths/year Parenterally administered penicillin accounts for 100 to 500 deaths per year Hymenoptera stings account for 40 to 100 deaths per

More information

Diagnosing and managing peanut allergy in children

Diagnosing and managing peanut allergy in children Diagnosing and managing peanut allergy in children Tibbott R, Clark A, Diagnosing and managing peanut allergy in children. Practitioner 2014;258 (1772):21-24 Dr Rebecca Tibbott MBBS BSc MRCPCH Academic

More information

Cows' milk hypersensitivity: immediate and delayed

Cows' milk hypersensitivity: immediate and delayed Archives of Disease in Childhood, 1983, 58, 856-862 Cows' milk hypersensitivity: immediate and delayed onset clinical patterns R P K FORD, D J HILL, AND C S HOSKING Departments of Gastroenterology and

More information

Oral and Sublingual Immunotherapy for Food Allergy

Oral and Sublingual Immunotherapy for Food Allergy Oral and Sublingual Immunotherapy for Food Allergy Wesley Burks, M.D. Curnen Distinguished Professor and Chair Department of Pediatrics University of North Carolina Faculty disclosure FINANCIAL INTERESTS

More information

Terms What is Anaphylaxis? Causes Signs & Symptoms Management Education Pictures Citations. Anaphylaxis; LBodak

Terms What is Anaphylaxis? Causes Signs & Symptoms Management Education Pictures Citations. Anaphylaxis; LBodak Leslie Bodak, EMT-P Terms What is Anaphylaxis? Causes Signs & Symptoms Management Education Pictures Citations Allergic Reaction: an abnormal immune response the body develops when a person has been previously

More information

Test Name Results Units Bio. Ref. Interval ALLERGY, INDIVIDUAL MARKER, BANANA, SERUM (FEIA) 0.42 kua/l

Test Name Results Units Bio. Ref. Interval ALLERGY, INDIVIDUAL MARKER, BANANA, SERUM (FEIA) 0.42 kua/l LL - LL-ROHINI (NATIONAL REFERENCE 135091547 Age 28 Years Gender Female 1/9/2017 120000AM 1/9/2017 103610AM 1/9/2017 14658M Ref By Final ALLERGY, INDIVIDUAL MARKER, BANANA, SERUM 0.42 kua/l QUANTITATIVE

More information

ANAPHYLAXIS POLICY & PROCEDURES

ANAPHYLAXIS POLICY & PROCEDURES PHOENIX P-12 COMMUNITY COLLEGE ANAPHYLAXIS POLICY & PROCEDURES Policy Statement Anaphylaxis is a severe, rapidly progressive allergic reaction that involves various areas of the body simultaneously and

More information

Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract

Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract Harold S. Nelson, MD, Jennie Lahr, AB, Rosemary Rule, RN, MS, Allen Bock, MD, and Donald Leung,

More information

Michaela Lucas. Clinical Immunologist/Immunopathologist. Pathwest, QE2 Medical Centre, Princess Margaret Hospital

Michaela Lucas. Clinical Immunologist/Immunopathologist. Pathwest, QE2 Medical Centre, Princess Margaret Hospital Michaela Lucas Clinical Immunologist/Immunopathologist Pathwest, QE2 Medical Centre, Princess Margaret Hospital School of Medicine and Pharmacology, School of Pathology and Laboratory Medicine University

More information

Patterns of sensitization to peanut allergen components in Taiwanese Preschool children

Patterns of sensitization to peanut allergen components in Taiwanese Preschool children Journal of Microbiology, Immunology and Infection (2012) 45, 90e95 Available online at www.sciencedirect.com journal homepage: www.e-jmii.com ORIGINAL ARTICLE Patterns of sensitization to peanut allergen

More information

Allergy Skin Prick Testing

Allergy Skin Prick Testing Allergy Skin Prick Testing What is allergy? The term allergy is often applied erroneously to a variety of symptoms induced by exposure to a wide range of environmental or ingested agents. True allergy

More information

EPI PEN TRAINING KAREN, RN, BSN FARGO SOUTH SCHOOL NURSE

EPI PEN TRAINING KAREN, RN, BSN FARGO SOUTH SCHOOL NURSE EPI PEN TRAINING KAREN, RN, BSN FARGO SOUTH SCHOOL NURSE Why use an Epipen? Anaphylaxis Anaphylaxis is a severe, potentially lifethreatening allergic reaction caused by contact with certain triggers CAUSES

More information

Allergic Rhinitis: Effects on Quality of Life and Co-morbid Conditions

Allergic Rhinitis: Effects on Quality of Life and Co-morbid Conditions Disclosures : Effects on Quality of Life and Co-morbid Conditions Nycomed Pharmaceutical Sepracor Pharmaceutical Michael S. Blaiss, MD Clinical Professor of Pediatrics and Medicine University of Tennessee

More information

Faith Lutheran College, Redlands Faith in Christ prepared for life A I ANAPHYLAXIS POLICY T H. Last updated June 2017

Faith Lutheran College, Redlands Faith in Christ prepared for life A I ANAPHYLAXIS POLICY T H. Last updated June 2017 F Faith Lutheran College, Redlands Faith in Christ prepared for life A I ANAPHYLAXIS POLICY T H Last updated June 2017 Food Allergy Policy and Procedures Rationale: Within the general community, there

More information

What is an allergy? Who gets allergies?

What is an allergy? Who gets allergies? ALLERGY Allergic disorders are on the increase both in this country and across Europe, affecting between 10 and 30% of the population. Allergies come in many forms, ranging from eczema, asthma, hay fever,

More information

Food Allergies and Intolerances: A Dieticians Role. Sareena Smith Spring 2010

Food Allergies and Intolerances: A Dieticians Role. Sareena Smith Spring 2010 Food Allergies and Intolerances: A Dieticians Role Sareena Smith Spring 2010 Overview! Allergy vs. Intolerances! Food Allergies & Symptoms! Food Intolerances & Symptoms! Diagnosis and Treatment! Research

More information

Online Nutrition Training Course

Online Nutrition Training Course Expert advice, Excellent results Online Nutrition Training Course Module 26: Food Allergies and Intolerances www.diet-specialist.co.uk Notice of Rights All rights reserved. No part of this publication

More information